ProShare Advisors’s Epizyme, Inc EPZM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $19K | Sell |
|
|||||
|
2022
Q1 | $50K | Buy |
|
|||||
|
2021
Q4 | $87K | Buy |
|
|||||
|
2021
Q3 | $171K | Sell |
|
|||||
|
2021
Q2 | $346K | Buy |
|
|||||
|
2021
Q1 | $330K | Buy |
|
|||||
|
2020
Q4 | $385K | Buy |
|
|||||
|
2020
Q3 | $326K | Sell |
|
|||||
|
2020
Q2 | $454K | Buy |
|
|||||
|
2020
Q1 | $279K | Sell |
|
|||||
|
2019
Q4 | $779K | Sell |
|
|||||
|
2019
Q3 | $345K | Buy |
|
|||||
|
2019
Q2 | $412K | Sell |
|
|||||
|
2019
Q1 | $414K | Buy |
|
|||||
|
2018
Q4 | $204K | Sell |
|
|||||
|
2018
Q3 | $368K | Sell |
|
|||||
|
2018
Q2 | $489K | Sell |
|
|||||
|
2018
Q1 | $680K | Sell |
|
|||||
|
2017
Q4 | $560K | Buy |
|
|||||
|
2017
Q3 | $681K | Buy |
|
|||||
|
2017
Q2 | $507K | Sell |
|
|||||
|
2017
Q1 | $610K | Sell |
|
|||||
|
2016
Q4 | $542K | Buy |
|
|||||
|
2016
Q3 | $398K | Sell |
|
|||||
|
2016
Q2 | $487K | Buy |
|
|||||
|
2016
Q1 | $572K | Buy |
|
|||||
|
2015
Q4 | $605K | Buy |
|
|||||
|
2015
Q3 | $441K | Sell |
|
|||||
|
2015
Q2 | $878K | Buy |
|
|||||
|
2015
Q1 | $563K | Buy |
|
|||||
|
2014
Q4 | $479K | Buy |
|
|||||
|
2014
Q3 | $607K | Sell |
|
|||||
|
2014
Q2 | $821K | Sell |
|
|||||
|
2014
Q1 | $726K | Buy |
|
|||||
|
2013
Q4 | $268K | Buy |
|